ifosfamide has been researched along with Adenocarcinoma Of Kidney in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcomatoid renal cell carcinoma (SRCC) is a heterogeneous disease with generally unreliable response to various therapies in clinical studies." | 1.33 | Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma. ( Bissada, NK; Chaudhary, UB; Rashid, MH; Welsh, CT, 2005) |
| "They were 26 bladder cancers and 19 renal cell cancers." | 1.30 | Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer. ( Fujita, K; Hirano, Y; Suzuki, K; Ushiyama, T, 1999) |
| "All patients had histologically proven renal cell carcinoma with widespread metastases." | 1.27 | [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs]. ( Akimoto, M; Hara, M; Hasegawa, J; Hirasawa, S; Kanamori, S; Kawamura, N; Nishimura, T; Ohhara, M; Okumura, S; Yoshida, K, 1984) |
| "In view of the divergent reports on the efficacy of ifosfamide in metastatic renal cell cancer, we tested this drug as monotherapy in nine patients on a dosage schedule of intravenous infusion of 40 mg/kg per day on days 1-5, repeated every 4 wk." | 1.27 | Ifosfamide chemotherapy of metastatic renal cell cancer. ( Baki, M; Bodrogi, I; Eckhardt, S; Sinkovics, I, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carden, MA | 1 |
| Perdahl-Wallace, E | 1 |
| Greenberg, J | 1 |
| McCarty, JM | 1 |
| Apolo, AB | 1 |
| Ostrovnaya, I | 1 |
| Halabi, S | 1 |
| Iasonos, A | 1 |
| Philips, GK | 1 |
| Rosenberg, JE | 1 |
| Riches, J | 1 |
| Small, EJ | 1 |
| Milowsky, MI | 1 |
| Bajorin, DF | 1 |
| Escudier, B | 1 |
| Droz, JP | 2 |
| Rolland, F | 1 |
| Terrier-Lacombe, MJ | 1 |
| Gravis, G | 1 |
| Beuzeboc, P | 1 |
| Chauvet, B | 1 |
| Chevreau, C | 1 |
| Eymard, JC | 1 |
| Lesimple, T | 1 |
| Merrouche, Y | 1 |
| Oudard, S | 1 |
| Priou, F | 1 |
| Guillemare, C | 1 |
| Gourgou, S | 1 |
| Culine, S | 1 |
| Rashid, MH | 1 |
| Welsh, CT | 1 |
| Bissada, NK | 1 |
| Chaudhary, UB | 1 |
| Keaney, CM | 1 |
| Springate, JE | 1 |
| Okumura, S | 1 |
| Nishimura, T | 1 |
| Yoshida, K | 1 |
| Ohhara, M | 1 |
| Hasegawa, J | 1 |
| Hirasawa, S | 1 |
| Hara, M | 1 |
| Kawamura, N | 1 |
| Kanamori, S | 1 |
| Akimoto, M | 1 |
| Hirano, Y | 1 |
| Ushiyama, T | 1 |
| Suzuki, K | 1 |
| Fujita, K | 1 |
| Bangalore, N | 1 |
| Bhargava, P | 2 |
| Hawkins, MJ | 1 |
| König, HJ | 1 |
| Gutmann, W | 1 |
| Weissmüller, J | 1 |
| Bodrogi, I | 1 |
| Baki, M | 1 |
| Sinkovics, I | 1 |
| Eckhardt, S | 1 |
| Theodore, C | 1 |
| Ghosn, M | 1 |
| Lupera, H | 1 |
| Piot, G | 1 |
| De Forges, A | 1 |
| Klink, M | 1 |
| Rouesse, J | 1 |
| Amiel, JL | 1 |
2 reviews available for ifosfamide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Cancer and the kidney.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Renal Cell; Comorbi | 2005 |
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Dacarbazine; Doxorubicin; Hum | 2001 |
2 trials available for ifosfamide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carc | 2002 |
Ifosfamide, vindesine and recombinant alpha-interferon combination chemotherapy for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; | 1991 |
7 other studies available for ifosfamide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxoru | 2018 |
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C | 2013 |
Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Female; Humans; | 2005 |
[Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Renal Cell; Cispl | 1984 |
Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drug Resistance; Drug Sc | 1999 |
Ifosfamide chemotherapy of metastatic renal cell cancer.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Ifosfamide; Infusions, Intravenous; Kidney Neopl | 1988 |
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 1988 |